1. Home
  2. PKE vs ZURA Comparison

PKE vs ZURA Comparison

Compare PKE & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$30.39

Market Cap

463.2M

Sector

Industrials

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.70

Market Cap

521.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
ZURA
Founded
1954
2022
Country
United States
United States
Employees
N/A
30
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.2M
521.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
PKE
ZURA
Price
$30.39
$5.70
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$13.00
AVG Volume (30 Days)
235.6K
550.3K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
1.69%
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$79.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$0.99
52 Week High
$29.85
$7.25

Technical Indicators

Market Signals
Indicator
PKE
ZURA
Relative Strength Index (RSI) 65.03 44.10
Support Level $17.99 $5.49
Resistance Level N/A $5.75
Average True Range (ATR) 1.30 0.47
MACD 0.16 -0.02
Stochastic Oscillator 82.55 40.16

Price Performance

Historical Comparison
PKE
ZURA

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: